The activated PI3K/Akt pathway can promote rapid cell growth and the development of multidrug resistance in tumor cells via dysregulate breast cancer cells’ survival, proliferation, apoptosis, and other processes [16]. This evidence concerns the gene AKT1 and breast cancer.